Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...

The U.S. norms, adopted at the height of the abuse scandal there, say a priest will be permanently removed from church ...

Old Town Med Spa is among those being accused of using false advertising and deceptive marketing practices to sell ...

Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients ...

Silence Therapeutics presented what seemed like positive data on zerlasiran, its experimental drug for reducing ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

As you know, our shared priority in TIME101 is to be a cash flow positive company in 2025. Reaching this goal will allow us ...

Verge Genomics announced that Eli Lilly (LLY) has opted to pursue the development of therapeutics against two validated drug targets for ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

Obviously, this list will be heavy on the Cucalorus Film Festival this week, but it also includes several non-Cucalorus ...

Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer ...